How many insider trades does FilingIQ track for RNTX?

FilingIQ tracks 7 Form 4 insider transactions for RNTX (Rein Therapeutics, Inc.), covering filings from Oct 24, 2025 onwards. 2 of those were filed in the last 90 days.

Are RNTX insiders net buyers or net sellers?

Across the full Form 4 history for RNTX, 6 transactions (86%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RNTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RNTX in?

Rein Therapeutics, Inc. (RNTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.38M.

RNTX insider trading

NasdaqCM Healthcare

Rein Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

86% / 0%

Market cap

$33.38M

About Rein Therapeutics, Inc.

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.

Company website: www.reintx.com

RNTX insider activity at a glance

FilingIQ has scored 7 insider transactions for RNTX since Oct 24, 2025. The most recent filing in our index is dated May 8, 2026.

Across the full history, 6 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RNTX insider trades is 49.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RNTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for RNTX?: FilingIQ tracks 7 Form 4 insider transactions for RNTX (Rein Therapeutics, Inc.), covering filings from Oct 24, 2025 onwards. 2 of those were filed in the last 90 days.
Are RNTX insiders net buyers or net sellers?: Across the full Form 4 history for RNTX, 6 transactions (86%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RNTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RNTX in?: Rein Therapeutics, Inc. (RNTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.38M.

Methodology & sources

Every RNTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.